Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-15-246754
Filing Date
2015-07-07
Accepted
2015-07-07 16:01:30
Documents
5
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d10636d10ka.htm 10-K/A 24535
2 EX-10.26 d10636dex1026.htm EX-10.26 123205
3 EX-10.29 d10636dex1029.htm EX-10.29 642486
4 EX-31.1 d10636dex311.htm EX-31.1 2715
5 EX-31.2 d10636dex312.htm EX-31.2 2699
  Complete submission text file 0001193125-15-246754.txt   796770
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

EIN.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34921 | Film No.: 15976622
SIC: 2834 Pharmaceutical Preparations